Patents by Inventor Susanna A. Saakian

Susanna A. Saakian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10966944
    Abstract: Administration of a salt of bicyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: April 6, 2021
    Inventor: Susanna A. Saakian
  • Patent number: 10751307
    Abstract: Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: August 25, 2020
    Inventor: Susanna A. Saakian
  • Publication number: 20200215008
    Abstract: Administration of a salt of bicyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Application
    Filed: March 18, 2020
    Publication date: July 9, 2020
    Inventor: Susanna A. Saakian
  • Publication number: 20180200211
    Abstract: Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 19, 2018
    Inventor: Susanna A. SAAKIAN
  • Patent number: 9943493
    Abstract: Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: April 17, 2018
    Assignee: ASE Pharmaceuticals, LLC
    Inventor: Susanna A. Saakian
  • Publication number: 20170000750
    Abstract: Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Application
    Filed: September 15, 2016
    Publication date: January 5, 2017
    Inventor: Susanna A. SAAKIAN
  • Publication number: 20110313037
    Abstract: Administration of a salt of bi-cyclo[2.2.2]octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
    Type: Application
    Filed: December 21, 2009
    Publication date: December 22, 2011
    Inventor: Susanna A. Saakian